These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 23864310)
1. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Kent DM; Ruthazer R; Weimar C; Mas JL; Serena J; Homma S; Di Angelantonio E; Di Tullio MR; Lutz JS; Elkind MS; Griffith J; Jaigobin C; Mattle HP; Michel P; Mono ML; Nedeltchev K; Papetti F; Thaler DE Neurology; 2013 Aug; 81(7):619-25. PubMed ID: 23864310 [TBL] [Abstract][Full Text] [Related]
2. Comparison of atrial septal defect and patent foramen ovale in cryptogenic strokes. Delabays C; Correia P; Eeckhout E; Delabays A; Michel P J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107664. PubMed ID: 38428550 [TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial. Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L; JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037 [TBL] [Abstract][Full Text] [Related]
4. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Wessler BS; Thaler DE; Ruthazer R; Weimar C; Di Tullio MR; Elkind MS; Homma S; Lutz JS; Mas JL; Mattle HP; Meier B; Nedeltchev K; Papetti F; Di Angelantonio E; Reisman M; Serena J; Kent DM Circ Cardiovasc Imaging; 2014 Jan; 7(1):125-31. PubMed ID: 24214884 [TBL] [Abstract][Full Text] [Related]
5. The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke. Kent DM; Thaler DE; Trials; 2011 Jul; 12():185. PubMed ID: 21794121 [TBL] [Abstract][Full Text] [Related]
6. Is patent foramen ovale a modifiable risk factor for stroke recurrence? Kent DM; Thaler DE Stroke; 2010 Oct; 41(10 Suppl):S26-30. PubMed ID: 20876498 [TBL] [Abstract][Full Text] [Related]
7. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review. Mazzucco S; Li L; Rothwell PM JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255 [TBL] [Abstract][Full Text] [Related]
8. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Alsheikh-Ali AA; Thaler DE; Kent DM Stroke; 2009 Jul; 40(7):2349-55. PubMed ID: 19443800 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between patent foramen ovale and cryptogenic stroke in a retrospective hospital-based study]. Böjti P; Bartha NE; May Z; Bereczki D; Fülöp S; Szakács Z; Szilágyi G Ideggyogy Sz; 2018 May; 71(5-06):169-177. PubMed ID: 29889459 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Patent Foramen Ovale in North Indian Cryptogenic Young Strokes. Khurana D; Petluri G; Kumar M; Bahl A; Kumar A; Gairolla J; Prabhakar S Neurol India; 2022; 70(3):1077-1082. PubMed ID: 35864642 [TBL] [Abstract][Full Text] [Related]
11. Cardiac and Echocardiographic Markers in Cryptogenic Stroke with Incidental Patent Foramen Ovale. Tateishi Y; Ueno Y; Tsujino A; Kuriki A; Kamiya Y; Shimizu T; Doijiri R; Yamaguchi E; Kikuno M; Shimada Y; Takekawa H; Koga M; Ihara M; Hirata K; Hasegawa Y; Toyoda K; Hattori N; Urabe T; J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105892. PubMed ID: 34107415 [TBL] [Abstract][Full Text] [Related]
12. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction. Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832 [TBL] [Abstract][Full Text] [Related]
13. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials. Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192 [TBL] [Abstract][Full Text] [Related]
17. Closure of patent foramen ovale in cryptogenic stroke: a never ending story. Calvet D; Mas JL Curr Opin Neurol; 2014 Feb; 27(1):13-9. PubMed ID: 24300793 [TBL] [Abstract][Full Text] [Related]
18. Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. Thaler DE; Ruthazer R; Di Angelantonio E; Di Tullio MR; Donovan JS; Elkind MS; Griffith J; Homma S; Jaigobin C; Mas JL; Mattle HP; Michel P; Mono ML; Nedeltchev K; Papetti F; Serena J; Weimar C; Kent DM Stroke; 2013 Mar; 44(3):675-80. PubMed ID: 23339957 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of Patent Foramen Ovale in a Cohort of Children With Cryptogenic Ischemic Stroke. Shih EK; Beslow LA; Natarajan SS; Falkensammer CB; Messé SR; Ichord RN Neurology; 2021 Nov; 97(21):e2096-e2102. PubMed ID: 34649876 [TBL] [Abstract][Full Text] [Related]
20. Transcatheter closure of patent foramen ovale in patients older than 60 years of age with cryptogenic embolism. Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Del Val D; Côté M; Rodés-Cabau J Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):219-224. PubMed ID: 31585849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]